OR4C12 Antibody

What is OR4C12 and why is it significant for research?

OR4C12 (Olfactory receptor 4C12) is a member of the olfactory receptor gene family involved in detecting odor molecules. This receptor plays a crucial role in the olfactory system, contributing to the detection and discrimination of various odorants. As a member of the G-protein coupled receptor 1 family, OR4C12 is a multi-pass membrane protein with a molecular mass of approximately 34.491 kDa in humans . Located on chromosome 11p11.12, it represents an important target for research into sensory perception and olfactory function . Understanding OR4C12 is essential for elucidating the complexities of olfactory signaling and its implications for behaviors such as food preferences, mating behaviors, and even disease detection . Research into OR4C12 contributes to our broader understanding of sensory biology and neurological disorders related to olfactory dysfunction.

What types of OR4C12 antibodies are available for research, and how do they differ?

The primary OR4C12 antibodies available for research include polyclonal antibodies such as PACO01229, which is derived from rabbit host species and shows high specificity for human OR4C12 . These antibodies have been developed by immunizing animals with synthesized peptides derived from the C-terminal region of human Olfactory receptor 4C12 . Polyclonal antibodies like these contain a mixture of immunoglobulins that recognize different epitopes on the OR4C12 protein.

The available OR4C12 antibodies typically differ in:

• Host species (predominantly rabbit for OR4C12)

• Clonality (polyclonal vs. monoclonal)

• Target epitopes (specific regions of the OR4C12 protein)

• Validated applications (WB, IF, ELISA, etc.)

• Recommended working dilutions

For accurate research results, it's crucial to select an antibody validated for your specific application and sample type. When evaluating different antibodies, researchers should consider validation data showing specificity to OR4C12 in tissues known to express the protein positively and negatively .

What are the validated applications for OR4C12 antibodies?

OR4C12 antibodies like PACO01229 have been validated for multiple research applications, providing flexibility in experimental design. The primary validated applications include:

• Western Blot (WB): Validated for protein detection with recommended dilutions of 1:500-1:2000

• Immunofluorescence (IF): Validated for cellular localization studies with recommended dilutions of 1:200-1:1000

• ELISA: Validated for quantitative protein detection

For optimal results in these applications, researchers should follow the manufacturer's recommended dilutions and protocols. The antibody's storage buffer (liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide) helps maintain stability during storage and use . Understanding these validated applications helps researchers design appropriate experiments to investigate OR4C12 expression, localization, and function in various cellular contexts.

How should OR4C12 antibodies be used in Western Blot experiments?

When using OR4C12 antibodies for Western Blot (WB) experiments, researchers should follow these methodological guidelines:

• Sample Preparation:

  • Extract proteins from tissues or cells known to express OR4C12

  • Use appropriate lysis buffers containing protease inhibitors

  • Quantify protein concentration and prepare equal loading amounts

• Gel Electrophoresis and Transfer:

  • Separate proteins using SDS-PAGE (10-12% gels recommended)

  • Transfer proteins to PVDF or nitrocellulose membranes

• Antibody Incubation:

  • Block membranes with 5% non-fat milk or BSA in TBST

  • Dilute OR4C12 antibody (e.g., PACO01229) in blocking buffer at 1:500-1:2000

  • Incubate overnight at 4°C with gentle agitation

  • Wash thoroughly with TBST buffer

• Detection:

  • Incubate with appropriate HRP-conjugated secondary antibody

  • Use enhanced chemiluminescence (ECL) detection system

  • Expected band size for OR4C12: approximately 34.5 kDa

• Controls:

  • Include positive controls (tissues/cells expressing OR4C12)

  • Include negative controls (tissues/cells not expressing OR4C12)

  • Consider using a loading control (β-actin, GAPDH)

Since OR4C12 antibodies have been affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen , they should provide specific detection when used at the recommended concentrations. Researchers should optimize dilutions based on their specific samples and detection systems.

What protocol should be followed for immunofluorescence studies using OR4C12 antibodies?

For immunofluorescence (IF) studies with OR4C12 antibodies, follow this detailed methodology:

• Sample Preparation:

  • For cultured cells: Grow cells on coverslips, fix with 4% paraformaldehyde (10-15 minutes)

  • For tissue sections: Prepare frozen or paraffin sections, perform antigen retrieval if needed

  • Permeabilize with 0.1-0.5% Triton X-100 (5-10 minutes for cells, longer for tissues)

• Blocking:

  • Block with 5-10% normal serum (from the species of the secondary antibody) in PBS

  • Include 0.1-0.3% Triton X-100 and 1% BSA in blocking solution

  • Block for 1 hour at room temperature

• Primary Antibody Incubation:

  • Dilute OR4C12 antibody to 1:200-1:1000 in blocking buffer

  • Incubate overnight at 4°C in a humidified chamber

  • Wash 3× with PBS (5 minutes each)

• Secondary Antibody Incubation:

  • Use fluorophore-conjugated anti-rabbit secondary antibody

  • Dilute according to manufacturer's recommendations

  • Incubate for 1-2 hours at room temperature

  • Wash 3× with PBS (5 minutes each)

• Counterstaining and Mounting:

  • Counterstain nuclei with DAPI (1:1000 in PBS, 5 minutes)

  • Mount with anti-fade mounting medium

  • Seal edges with nail polish

• Imaging:

  • Use appropriate filter sets for the chosen fluorophores

  • Capture images at different magnifications

  • Include z-stack images for colocalization studies

When conducting IF studies with OR4C12 antibodies, it's essential to include proper controls and to optimize antibody concentrations, as background fluorescence can be an issue with olfactory receptor antibodies. Since OR4C12 is a multi-pass membrane protein , researchers should pay particular attention to membrane staining patterns.

How can researchers validate the specificity of OR4C12 antibodies?

Validating antibody specificity is crucial for reliable research outcomes. For OR4C12 antibodies, implement these validation approaches:

• Positive and Negative Control Tissues/Cells:

  • Test the antibody on tissues known to express OR4C12 (positive controls)

  • Test on tissues known not to express OR4C12 (negative controls)

  • Companies like Boster Bio validate their antibodies using this approach

• Western Blot Validation:

  • Confirm detection of a single band at the expected molecular weight (34.491 kDa)

  • Perform peptide competition assay: pre-incubate antibody with immunizing peptide

  • Compare with another antibody targeting a different epitope of OR4C12

• Genetic Validation:

  • Test on OR4C12 knockout or knockdown cells/tissues

  • Use OR4C12 overexpression systems as positive controls

• Cross-Reactivity Testing:

  • Test against related olfactory receptors to ensure specificity

  • Similar to how 3D12 and 4D12 antibodies were tested against HLA panels

• Immunoprecipitation-Mass Spectrometry:

  • Immunoprecipitate with OR4C12 antibody and identify pulled-down proteins

  • Confirm OR4C12 presence using mass spectrometry

• Correlation with mRNA Expression:

  • Compare antibody staining with OR4C12 mRNA expression (RT-PCR or RNA-seq)

  • Check correlation between protein and mRNA levels across multiple samples

Proper validation ensures that experimental results truly reflect OR4C12 biology rather than non-specific binding or artifacts. This comprehensive validation approach mirrors the rigorous testing performed for other research antibodies like those against HLA-E, where epitope mapping and cross-reactivity testing were employed to ensure specificity .

How can OR4C12 antibodies be used to study olfactory receptor signaling pathways?

OR4C12 antibodies can serve as powerful tools for investigating olfactory receptor signaling through several advanced experimental approaches:

• Co-immunoprecipitation (Co-IP) Studies:

  • Use OR4C12 antibodies to pull down receptor complexes

  • Identify interacting proteins that form part of the signaling cascade

  • Analyze how these interactions change upon odor stimulation

  • Recommended protocol: Use affinity-purified antibodies like PACO01229 with optimized lysis conditions that preserve membrane protein interactions

• Receptor Trafficking and Internalization:

  • Employ immunofluorescence with OR4C12 antibodies to track receptor localization

  • Examine changes in receptor distribution after ligand binding

  • Use live-cell imaging with fluorophore-conjugated Fab fragments of OR4C12 antibodies

  • Similar to temperature-dependent trafficking studies performed with 3D12 and 4D12 antibodies

• Signaling Cascade Activation:

  • Use OR4C12 antibodies to detect post-translational modifications (phosphorylation)

  • Combine with phospho-specific antibodies against downstream effectors

  • Track temporal changes in signaling after receptor stimulation

• Conformational Changes Upon Activation:

  • Develop conformation-specific OR4C12 antibodies that recognize active/inactive states

  • Similar to how 4D12 antibody preferentially binds peptide-free HLA-E

  • Use these to quantify receptor activation states under different conditions

• Heterologous Expression Systems Analysis:

  • Compare signaling in native tissues versus heterologous expression systems

  • Use OR4C12 antibodies to normalize for expression levels

  • Quantify receptor density and correlate with signaling efficiency

This multifaceted approach can provide insights into how OR4C12 converts chemical signals (odorants) into cellular responses, potentially revealing novel aspects of olfactory signaling mechanisms that may be applicable to other G-protein coupled receptors.

What are the challenges in detecting and localizing olfactory receptors like OR4C12?

Detecting and localizing olfactory receptors like OR4C12 presents several significant challenges that researchers must address:

• Low Expression Levels:

  • Olfactory receptors typically have low expression levels outside the olfactory epithelium

  • Requires highly sensitive detection methods and signal amplification

  • Solution: Use tyramide signal amplification or highly sensitive detection systems

• Membrane Protein Accessibility:

  • OR4C12 is a multi-pass membrane protein , making epitopes difficult to access

  • Optimal epitope selection is crucial for antibody development

  • Solution: Use antibodies targeting extracellular domains or optimize permeabilization

• Cross-Reactivity Issues:

  • High sequence similarity among olfactory receptor family members

  • Potential for antibody cross-reactivity with related receptors

  • Solution: Validate antibody specificity using the methods outlined in section 2.3

• Protein Conformation Dependence:

  • Epitope accessibility may depend on receptor conformation

  • Similar to how 4D12 preferentially binds peptide-free forms of HLA-E

  • Solution: Use multiple antibodies targeting different epitopes

• Tissue Fixation Effects:

  • Fixation can alter protein structure and epitope accessibility

  • Especially problematic for multi-pass membrane proteins like OR4C12

  • Solution: Optimize fixation protocols (time, temperature, fixative type)

• Receptor Trafficking and Internalization:

  • Olfactory receptors undergo dynamic trafficking

  • Difficult to distinguish surface from internalized receptors

  • Solution: Use non-permeabilized/permeabilized paired staining to differentiate

To address these challenges, researchers should employ multiple complementary techniques (immunoblotting, immunofluorescence, flow cytometry) and use appropriate controls to validate findings. Additionally, considering the use of epitope tags in heterologous expression systems can provide alternative detection methods when antibody-based detection proves challenging.

How do polyclonal and monoclonal OR4C12 antibodies compare in research applications?

Polyclonal and monoclonal OR4C12 antibodies offer distinct advantages and limitations that researchers should consider based on their specific experimental needs:

Application-Specific Considerations:

• Western Blotting:

  • Polyclonal antibodies like PACO01229 offer good sensitivity at 1:500-1:2000 dilutions

  • Useful for detecting denatured OR4C12 protein

• Immunofluorescence:

  • Polyclonal antibodies provide stronger signal through multiple epitope binding

  • Recommended dilutions of 1:200-1:1000 for IF applications

• ELISA/Quantitative Applications:

  • Monoclonal antibodies offer more consistent quantification

  • Polyclonal antibodies may provide better antigen capture

• Challenging Sample Types:

  • Polyclonal antibodies may perform better in fixed tissues where some epitopes are masked

  • Monoclonal antibodies offer cleaner results in samples with potential cross-reactive proteins

How can researchers address high background when using OR4C12 antibodies in immunostaining?

High background is a common challenge when using antibodies against olfactory receptors like OR4C12. Here are comprehensive strategies to address this issue:

• Antibody Dilution Optimization:

  • Perform titration experiments with various antibody dilutions

  • Start with the recommended range (1:200-1:1000 for IF) but be prepared to dilute further

  • Find the optimal concentration that maximizes specific signal while minimizing background

• Blocking Protocol Enhancement:

  • Extend blocking time (2-3 hours at room temperature or overnight at 4°C)

  • Test different blocking agents: BSA, normal serum, commercial blockers

  • Use a mixture of blockers (e.g., 5% normal serum + 1% BSA)

  • Add 0.1-0.3% Triton X-100 to blocking solution to reduce non-specific hydrophobic interactions

• Washing Optimization:

  • Increase the number of washes (5-6 washes instead of 3)

  • Extend wash duration (10-15 minutes per wash)

  • Add 0.05-0.1% Tween-20 to wash buffers

  • Use gentle agitation during washing

• Fixation Adjustments:

  • Test different fixatives (4% PFA, methanol, acetone)

  • Optimize fixation time (over-fixation can increase background)

  • For tissues, try fresh-frozen sections instead of paraffin

• Secondary Antibody Considerations:

  • Use highly cross-adsorbed secondary antibodies

  • Centrifuge secondary antibody solution before use (removes aggregates)

  • Pre-adsorb secondary antibody with tissue powder from the species being examined

• Additional Technical Approaches:

  • Include 0.1-0.3 M NaCl in antibody diluent to reduce electrostatic interactions

  • Add 5% non-fat dry milk to antibody diluent

  • Pre-incubate tissue with unconjugated secondary antibody host IgG

  • Use Sudan Black B (0.1-0.3%) after secondary antibody to reduce autofluorescence

These approaches should be tested systematically, changing one variable at a time. Document all conditions carefully to identify the optimal protocol for your specific sample type and application. This methodical approach mirrors techniques used to optimize other antibodies in challenging applications, such as those described for HLA-E antibodies .

What strategies can help optimize OR4C12 antibody performance in Western blot applications?

Optimizing OR4C12 antibody performance in Western blot requires attention to multiple technical aspects. Consider these comprehensive strategies:

• Sample Preparation Optimization:

  • Test different lysis buffers (RIPA, NP-40, Triton X-100)

  • For membrane proteins like OR4C12 , include specialized detergents (e.g., DDM, CHAPS)

  • Add protease inhibitors to prevent degradation

  • Avoid excessive heating of samples (use 37°C instead of 95°C for membrane proteins)

• Gel and Transfer Conditions:

  • Use gradient gels (4-20%) to improve resolution around OR4C12's 34.5 kDa size

  • Optimize transfer conditions for membrane proteins:

    • Longer transfer times (overnight at low voltage)

    • Add 0.05% SDS to transfer buffer to improve elution

    • Use PVDF membranes (0.2 μm pore size) for better protein retention

• Blocking Optimization:

  • Test different blocking agents (5% non-fat milk, 5% BSA, commercial blockers)

  • For phospho-detection, avoid milk (contains phosphoproteins)

  • Consider blocking time (1 hour at room temperature or overnight at 4°C)

• Antibody Incubation Parameters:

  • Optimize primary antibody dilution (start with 1:500-1:2000 as recommended)

  • Test different diluents (TBS-T with 1-5% blocking agent)

  • Vary incubation time and temperature (1-2 hours at room temperature vs. overnight at 4°C)

• Detection System Selection:

  • For low abundance proteins, use high-sensitivity ECL reagents

  • Consider fluorescent secondary antibodies for better quantification

  • For problematic detection, try biotin-streptavidin amplification systems

• Specialized Techniques for Membrane Proteins:

  • Avoid stripping and re-probing (can remove membrane proteins)

  • Load higher amounts of protein (50-100 μg)

  • Consider native PAGE for conformation-dependent epitopes

• Antibody Validation Controls:

  • Include positive control (tissue known to express OR4C12)

  • Include negative control (tissue not expressing OR4C12)

  • Consider peptide competition assay to confirm specificity

By systematically testing these variables, researchers can develop an optimized Western blot protocol specific for OR4C12 detection. Document all optimization steps carefully to ensure reproducibility across experiments. This methodical approach has proven effective for optimizing antibody performance in various challenging applications .

How can researchers evaluate batch-to-batch variability in OR4C12 antibodies?

Batch-to-batch variability can significantly impact experimental outcomes, especially with polyclonal antibodies like those available for OR4C12 . Here's a comprehensive approach to evaluate and mitigate this variability:

• Side-by-Side Comparison Testing:

  • Run parallel assays with old and new antibody batches

  • Use identical samples, concentrations, and protocols

  • Compare staining intensity, pattern, and background levels

  • Document differences with quantitative measurements when possible

• Standard Sample Analysis:

  • Maintain a "standard" sample set (positive and negative controls)

  • Test each new batch against these standards

  • Create a reference data set with images/blots from the original batch

  • Compare signal-to-noise ratios between batches

• Quantitative Assessment Methods:

  • For Western blots:

    • Measure band intensity using densitometry

    • Calculate signal-to-background ratios

    • Determine detection limits with serial dilutions

  • For immunofluorescence:

    • Measure fluorescence intensity

    • Analyze staining pattern consistency

    • Evaluate background levels quantitatively

• Adjusting for Batch Differences:

  • Perform antibody titration with each new batch

  • Adjust working dilutions based on titration results

  • Document optimal conditions for each batch

  • Consider lot reservation for critical long-term projects

• Pre-adsorption Testing:

  • Pre-adsorb antibody with the immunizing peptide

  • Compare specific signal reduction between batches

  • Helps assess specificity consistency between lots

• Epitope Verification:

  • If possible, test recognition of the specific epitope (C-terminal region of human OR4C12)

  • Compare epitope recognition efficiency between batches

  • Similar to epitope mapping approaches used for other antibodies

• Documentation and Reporting:

  • Maintain detailed records of lot numbers

  • Document all test results between batches

  • Include batch information in experimental methods

  • Consider reporting batch effects in publications

This structured approach allows researchers to quantify batch-to-batch variability and make appropriate adjustments to experimental protocols. For critical applications, researchers might consider purchasing larger quantities of a single batch or exploring the development of monoclonal antibodies, which typically display lower batch-to-batch variability. Similar approaches have been used to evaluate other research antibodies, ensuring experimental reproducibility .

What emerging applications exist for OR4C12 antibodies in neurosensory research?

OR4C12 antibodies are poised to contribute to several innovative research directions in neurosensory biology:

• Single-Cell Profiling of Olfactory Neurons:

  • Using OR4C12 antibodies to identify and isolate specific olfactory sensory neurons

  • Combining with single-cell transcriptomics to correlate receptor expression with gene signatures

  • Mapping the distribution of OR4C12-expressing neurons within the olfactory epithelium

  • This could reveal patterns similar to those observed in other receptor mapping studies

• Circuit Tracing and Connectivity:

  • Employing OR4C12 antibodies to label specific neuronal populations

  • Tracking axonal projections to glomeruli in the olfactory bulb

  • Investigating the convergence principles of OSNs expressing the same receptor

  • Could incorporate techniques similar to those used for tracking other receptor-defined neural populations

• Ectopic Expression of Olfactory Receptors:

  • Investigating OR4C12 expression in non-olfactory tissues

  • Using validated antibodies to detect unexpected receptor locations

  • Exploring potential non-olfactory functions of OR4C12

  • Similar to research revealing ectopic expression of other olfactory receptors in diverse tissues

• Receptor Dynamics and Turnover:

  • Studying the lifecycle of OR4C12 from synthesis to degradation

  • Examining receptor trafficking in response to odor exposure

  • Investigating homeostatic mechanisms regulating receptor levels

  • Could employ temperature-dependent trafficking approaches similar to those used with other receptor antibodies

• Comparative Olfactory Biology:

  • Using OR4C12 antibodies to study evolutionary conservation across species

  • Comparing receptor distribution and function in different animal models

  • Understanding species-specific adaptations in olfactory system organization

  • Would require careful validation of cross-species reactivity

These emerging applications could significantly advance our understanding of olfactory system organization and function, potentially revealing new principles of sensory coding and processing. The development of more specific tools, including monoclonal antibodies targeting different epitopes of OR4C12, would further enhance the value of these approaches in neurosensory research.

How might advances in antibody technology improve OR4C12 detection and characterization?

Emerging antibody technologies hold significant promise for enhancing OR4C12 research:

• Recombinant Antibody Development:

  • Creating fully recombinant OR4C12 antibodies with defined sequences

  • Advantages: elimination of batch-to-batch variability, renewable source

  • Application: consistent results across long-term studies and between laboratories

  • Unlike traditional polyclonal antibodies that show variability , recombinant antibodies offer unprecedented reproducibility

• Single-Domain Antibodies (Nanobodies):

  • Developing camelid-derived single-domain antibodies against OR4C12

  • Advantages: smaller size (15 kDa vs ~150 kDa), better tissue penetration, access to sterically hindered epitopes

  • Application: improved imaging of membrane-embedded receptors like OR4C12

  • Particularly valuable for accessing conformational epitopes in this multi-pass membrane protein

• Bi-specific Antibody Approaches:

  • Creating antibodies that simultaneously target OR4C12 and downstream signaling molecules

  • Advantages: detection of functional receptor complexes, spatial relationship analysis

  • Application: studying receptor-effector coupling in situ

  • Could reveal mechanistic insights into olfactory signal transduction

• Conformation-Specific Antibodies:

  • Developing antibodies that specifically recognize active/inactive OR4C12 conformations

  • Advantages: ability to measure receptor activation states in situ

  • Application: mapping activation patterns in response to different odorants

  • Similar to how 4D12 preferentially recognizes peptide-free forms of HLA-E

• Antibody Fragments and Derivatives:

  • Using Fab, scFv, or other antibody fragments for OR4C12 detection

  • Advantages: better tissue penetration, reduced non-specific binding

  • Application: improved imaging in thick tissue sections, live-cell imaging

  • Could overcome some of the challenges associated with full IgG molecules

• Proximity Labeling Combined with Antibodies:

  • Coupling OR4C12 antibodies with enzymes that catalyze biotin deposition (BioID, APEX)

  • Advantages: identification of proteins in proximity to OR4C12 in living cells

  • Application: mapping the OR4C12 protein interactome during signaling

  • Could reveal transient interactions in the olfactory signaling cascade

These technological advances could dramatically improve our ability to detect, localize, and characterize OR4C12 in various experimental contexts, overcoming many of the current limitations associated with conventional antibodies. The development and validation of these advanced tools will require careful epitope selection and extensive validation, similar to the rigorous approaches used for other receptor antibodies .